ANDA 71741, held by Quad Pharms. Acetylcysteine.
As of Nov 15, 2026, ANDA 71741 (Acetylcysteine), held by Quad Pharms, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Acetylcysteine20% ยท solution; inhalation, oral | Acetylcysteine | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
